The small study, published recently in the journal Obesity, looked at 34 patients who had already lost weight on GLP-1 ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...

NVO partners with HIMS to expand access to Ozempic and Wegovy via telehealth, aiming to shift patients from compounded GLP-1s to FDA-approved drugs.

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between ...

New research is taking a closer look at what can happen when people stop taking GLP-1 medications for a long period of time.

Pfizer China announced that the National Medical Products Administration (NMPA) has officially approved the new-generation ...

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor ...

Children and teens with type 2 diabetes are more likely to receive insulin than newer GLP-1 receptor agonists, according to a new study published in Pediatrics. Current guidelines from the American ...